A Randomized, Double-masked, Multicenter, Controlled Study of Photodynamic Therapy in Patients With Central Serous Chorioretinopathy
Phase of Trial: Phase IV
Latest Information Update: 17 Aug 2016
At a glance
- Drugs Verteporfin (Primary)
- Indications Central serous chorioretinopathy
- Focus Therapeutic Use
- 15 Aug 2016 Planned number of patients changed from 120 to 131.
- 15 Aug 2016 Status changed from recruiting to completed.
- 23 Sep 2015 New trial record